Loading viewer...
earnings
Format: PDF earnings
Alnylam Pharmaceuticals presents its fourth quarter and full year 2022 financial results, featuring commercial highlights for its approved RNAi therapeutics and pipeline updates. The presentation outlines progress on the company's P5x25 strategy and financial performance with discussions on commercial expansion and upcoming milestones.
presentation
earnings
19 Pages
Abu Dhabi National Energy Company
Dr. Reddy's Q3 FY23 Financial Results January 2023
earningsearnings
12 Pages
Dr. Reddy's Laboratories
Innovative Industrial Properties Q1 2023 Earnings Presentation
earningsearnings
19 Pages
Innovative Industrial Properties